Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
1 Correction to: Clinical Pharmacokinetics https://doi.org/10.1007/s40262-018-0721-y
Introduction section, para 3, lines 2–4 which previously read:
In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT02418455),…
In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT01856218),…
The original article was corrected.
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.